You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 開拓藥業-B(9939.HK)漲近4% 與京東健康簽署框架協議
格隆匯 06-29 10:23
格隆匯6月29日丨開拓藥業-B(9939.HK)現報16港元,漲3.9%,暫成交2161萬港元,最新總市值59億港元。開拓藥業昨日公佈,2020年6月20日,公司全資子公司蘇州開拓藥業股份有限公司與北京京東健康簽署框架協議。根據框架協議,雙方將就福瑞他恩(KX-826)在京東健康運營的線上藥品零售平台yiyaojd.com(“京東大藥房”)的銷售展開深入合作。公告稱,福瑞他恩正在進行中國的II期臨牀試驗和美國的Ib期臨牀試驗。和京東健康基於該框架協議的合作將提高集團在商業零售渠道的能力,從而為雙方創造互惠互利。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account